M. Corradetti
Molecular Biology · 2004
A researcher in the Science corpus: 2 papers; trusts 2 researchers and is trusted by 1 researcher here, as inferred from the citation graph.
Subfields
- Molecular Biology — 44 citations into it; #17,341 of 17,773 by trust here, #10,506 by citations
Whom M. Corradetti trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts M. Corradetti overall
Papers from M. Corradetti's perspective
Ordered by how strongly the researchers M. Corradetti trusts endorse each paper. Same corpus, a different order for every researcher.
- TSC2 mediates cellular energy response to control cell growth and survival. (Cell)
- Tsc tumour suppressor proteins antagonize amino-acid–TOR signalling (Nature Cell Biology)
- Role of AMP-activated protein kinase in mechanism of metformin action. (Journal of Clinical Investigation)
- Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR (Proceedings of the National Academy of Sciences of the United States of America)
- Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/akt pathway. (Molecules and Cells)
- Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. (Molecules and Cells)
- AMP‐activated protein kinase: the energy charge hypothesis revisited (Bioessays)
- The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins (Journal of Cell Biology)
- TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling (Nature Cell Biology)
- TOR signalling in bugs, brain and brawn (Nature reviews. Molecular cell biology)
Their papers
- Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome. (2004) — 595 citations
- Dysregulation of the TSC-mTOR pathway in human disease (2004) — 1,008 citations